Katlama C - Search Results

1

Izzedine H, Valantin MA, Daudon M, Mohand HA, Caby F, Katlama C. Izzedine H, et al. Among authors: katlama c. AIDS. 2007 Sep 12;21(14):1992. doi: 10.1097/QAD.0b013e3282ef792f. AIDS. 2007. PMID: 17721118 No abstract available.

2

Dideoxyinosine-associated hypokalaemia.

Katlama C, Tubiana R, Rosenheim M, Valantin MA, Caumes E, Bricaire F, Gentilini M. Katlama C, et al. Lancet. 1991 Jan 19;337(8734):183. doi: 10.1016/0140-6736(91)90854-i. Lancet. 1991. PMID: 1670826 No abstract available.

3

Renal insufficiency induced by ritonavir in HIV-infected patients.

Bochet MV, Jacquiaud C, Valantin MA, Katlama C, Deray G. Bochet MV, et al. Among authors: katlama c. Am J Med. 1998 Nov;105(5):457. Am J Med. 1998. PMID: 9831435 No abstract available.

4

[Immunologic reconstruction after antiretroviral treatment].

Tubiana R, Carcelain G, Mohand HA, Li TS, Renaud M, Blanc C, Calvez V, Debré P, Agut H, Katlama C, Autran B, Bricaire F. Tubiana R, et al. Among authors: katlama c. Presse Med. 1999 Feb 27;28(8):424-8. Presse Med. 1999. PMID: 10093603 French.

5

Low lipolytic enzyme activity in patients with severe hypertriglyceridemia on highly active antiretroviral therapy.

Baril L, Beucler I, Valantin MA, Bruckert E, Bonnefont-Rousselot D, Coutellier A, Caumes E, Katlama C, Bricaire F. Baril L, et al. Among authors: katlama c. AIDS. 2001 Feb 16;15(3):415-7. doi: 10.1097/00002030-200102160-00016. AIDS. 2001. PMID: 11273223 No abstract available.

6

Re-occurrence of HIV-1 drug mutations after treatment re-initiation following interruption in patients with multiple treatment failure.

Delaugerre C, Valantin MA, Mouroux M, Bonmarchand M, Carcelain G, Duvivier C, Tubiana R, Simon A, Bricaire F, Agut H, Autran B, Katlama C, Calvez V. Delaugerre C, et al. Among authors: katlama c. AIDS. 2001 Nov 9;15(16):2189-91. doi: 10.1097/00002030-200111090-00016. AIDS. 2001. PMID: 11684940 Clinical Trial.

7

Virologic outcome after switching from a nucleoside reverse transcriptase inhibitor to tenofovir in patients with undetectable HIV-1 RNA plasma level.

Wirden M, Marcelin AG, Tubiana R, Valantin MA, Ghosn J, Duvivier C, Dominguez S, Paris L, Agher R, Peytavin G, Katlama C, Calvez V. Wirden M, et al. Among authors: katlama c. J Acquir Immune Defic Syndr. 2004 Jul 1;36(3):876-8. doi: 10.1097/00126334-200407010-00016. J Acquir Immune Defic Syndr. 2004. PMID: 15213573 No abstract available.

8

Resistance profiles observed in virological failures after 24 weeks of amprenavir/ritonavir containing regimen in protease inhibitor experienced patients.

Marcelin AG, Affolabi D, Lamotte C, Mohand HA, Delaugerre C, Wirden M, Voujon D, Bossi P, Ktorza N, Bricaire F, Costagliola D, Katlama C, Peytavin G, Calvez V. Marcelin AG, et al. Among authors: katlama c. J Med Virol. 2004 Sep;74(1):16-20. doi: 10.1002/jmv.20140. J Med Virol. 2004. PMID: 15258963

9

Changing electrolyte and acido-basic profile in HIV-infected patients in the HAART era.

Isnard Bagnis C, Du Montcel ST, Fonfrede M, Jaudon MC, Thibault V, Carcelain G, Valantin MA, Izzedine H, Servais A, Katlama C, Deray G. Isnard Bagnis C, et al. Among authors: katlama c. Nephron Physiol. 2006;103(3):p131-8. doi: 10.1159/000092247. Epub 2006 Mar 23. Nephron Physiol. 2006. PMID: 16557032

10

Skin rash associated with atazanavir: report of three cases.

Ouagari Z, Tubiana R, Mohand HA, Dominguez S, Duvivier C, Bricaire F, Katlama C, Caumes E. Ouagari Z, et al. Among authors: katlama c. AIDS. 2006 May 12;20(8):1207-8. doi: 10.1097/01.aids.0000226965.17966.3c. AIDS. 2006. PMID: 16691076 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

932 results

Search Page